Cargando…
Targeting Metabolic Vulnerabilities in Epstein–Barr Virus-Driven Proliferative Diseases
SIMPLE SUMMARY: Discovered in 1964, Epstein-Barr virus was the first human cancer-causing virus identified. Cancer cells reprogram metabolic pathways to augment their ability to support abnormal rates of proliferation and promote spread through metastatic invasion. Over the course of an infection, E...
Autores principales: | Leung, Nicole Yong Ting, Wang, Liang Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341354/ https://www.ncbi.nlm.nih.gov/pubmed/37444521 http://dx.doi.org/10.3390/cancers15133412 |
Ejemplares similares
-
Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020) -
Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022) -
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020) -
The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980) -
Correction: Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)